GlaxoSmithKline PLC (NYSE:GSK) Given Price Target Of $49.5


As per GlaxoSmithKline PLC (NYSE:GSK)’s news release on 2016-07-27, its shareholders will get cash dividend of $0.494 per share. The recent press release updated on the record date and payout date, which stands at 2016-08-12 and 2016-10-13, respectively.

The stock will commence trading ex-dividend from 2016-08-10, until, which the shareholders are compelled to keep the holdings so as to qualify for the dividend. Evaluating the dividend distribution mode, it was noted that last year GlaxoSmithKline PLC (NYSE:GSK) disbursed $0.494 in dividend compared to distribution of $0.494, a year ago.

It highlights a sharp difference in cash payouts of the two years. This shows a major deviation of -9.7554%.

Analyst Perspective

The sell-side market professionals who track the firm’s financial and technical parameters have estimated GlaxoSmithKline PLC (NYSE:GSK) to attain a price target of $49.5. It is an average estimate figure given by 2 analysts tracking the stock. The estimates disclosed that the stock can move up on the chart and hit a high of $50. The low price range is set at $49 for next year while the arithmetic mean is seen at 2.

Eyeing Earnings GlaxoSmithKline PLC (NYSE:GSK) is likely to post quarterly numbers around 2016-10-26 for the quarter ending 2016-09-30. The quarterly EPS projection is set at $0.77 for the period ending on 2016-09-30.

In last quarter ended 2015-12-31, GlaxoSmithKline PLC (NYSE:GSK) earnings came at $0.7 suggesting a deviation of $0.15. The brokerages targeted EPS of $0.55 for the quarter.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 29 times, 1 visits today)